gabexate and leucine

gabexate has been researched along with leucine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fantini, L; Morselli-Labate, AM; Pezzilli, R1
Clavien, PA; Heinrich, S; Rousson, V; Schäfer, M1
Drosten, C; Erichsen, S; Herrler, G; Herrler, T; Hoffmann, M; Kleine-Weber, H; Krüger, N; Müller, MA; Nitsche, A; Pöhlmann, S; Schiergens, TS; Schroeder, S; Wu, NH1

Reviews

1 review(s) available for gabexate and leucine

ArticleYear
Evidence-based treatment of acute pancreatitis: a look at established paradigms.
    Annals of surgery, 2006, Volume: 243, Issue:2

    Topics: Acute Disease; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aprotinin; Cholecystectomy; Enteral Nutrition; Evidence-Based Medicine; Gabexate; Gastrointestinal Agents; Humans; Imidazoles; Imipenem; Leucine; Meropenem; Octreotide; Pancreatitis; Pancreatitis, Acute Necrotizing; Platelet Activating Factor; Randomized Controlled Trials as Topic; Serine Proteinase Inhibitors; Sphincterotomy, Endoscopic; Thienamycins

2006

Other Studies

2 other study(ies) available for gabexate and leucine

ArticleYear
New approaches for the treatment of acute pancreatitis.
    JOP : Journal of the pancreas, 2006, Jan-11, Volume: 7, Issue:1

    Topics: Acute Disease; Amylases; Animals; Antibodies, Monoclonal; Cholangiopancreatography, Endoscopic Retrograde; Clinical Trials as Topic; Drug Evaluation, Preclinical; Gabexate; Humans; Imidazoles; Infliximab; Interleukin-10; Leucine; Nutrition Therapy; Pain; Pancreatitis; Pancreatitis, Acute Necrotizing; Practice Guidelines as Topic; Probiotics; Treatment Outcome

2006
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Cell, 2020, 04-16, Volume: 181, Issue:2

    Topics: Ammonium Chloride; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; Betacoronavirus; Cell Line; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Development; Esters; Gabexate; Guanidines; Humans; Immunization, Passive; Leucine; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Vesiculovirus; Virus Internalization

2020